Since METTL3 is the most important methyltransferase for mRNA m6A modifications which play diverse functions in many biology processes and diseases, it is possible that METTL3 acts either oncogenic or tumor-suppressive roles in different stages of CRC progression by modulating different target pathways, as the previous reports37,38,40. The gene discussed is METTL3; the disease is neoplasm.